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HAND2 is an essential transcription factor for cardiac, pharyngeal arch, and limb development. Apoptosis in the HAND2-null embryo
causes hypoplasia of the right ventricle and pharyngeal arches leading to lethality by embryonic day (E)10.0 from heart failure. In order to
investigate the role of apoptosis in inducing the HAND2-null phenotype, we generated mouse embryos lacking both HAND2 and Apaf-1, a
central downstream mediator of mitochondrial damage-induced apoptosis. In contrast to HAND2/ embryos, HAND2/Apaf-1/
embryos at E10.5–11.0 had well-developed pharyngeal arches, aortic arch arteries, and no signs of cardiac failure. TUNEL analysis through
pharyngeal arches of HAND2/Apaf-1/ embryos revealed decreased apoptosis and the embryos had clearly patent aortic arch arteries.
However, ventricular hypoplasia and cell death were unchanged in these animals compared to HAND2/ embryos, resulting in growth
arrest at E11.0. Our study suggests that loss of HAND2 in the pharyngeal arch mesenchyme leads to apoptosis in an Apaf-1-dependent
fashion and that, while loss of aortic arch integrity contributes to the early lethality, the ventricular defects are independent of arch
development.
D 2004 Elsevier Inc. All rights reserved.
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Cell fate decisions of survival or death play a central
role in shaping the developing embryo and its organs.
While the triggers and effectors involved in programmed
cell death (apoptosis) are well studied (Hengartner, 2000),
relatively little is known regarding the transcription factors
that influence such decisions. HAND2 is a basic helix-
loop-helix (bHLH) transcription factor that is essential for
numerous embryologic events (Abe et al., 2002; Charite et0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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(D. Srivastava).al., 2000; Fernandez-Teran et al., 2000; Howard et al.,
2000; Srivastava et al., 1997; Thomas et al., 1998;
Yamagishi et al., 2000). In mouse, HAND2 is specifically
expressed in the developing heart, pharyngeal arch
mesenchyme, and posterior limb buds (Charite et al.,
2000; Srivastava et al., 1995; Thomas et al., 1998).
Embryos lacking HAND2 exhibit hypoplasia of the right
ventricle, aortic arch arteries, and pharyngeal arches, all of
which are associated with apoptosis of HAND2-expressing
cells (Srivastava et al., 1997; Thomas et al., 1998;
Yamagishi et al., 2001). However, the cellular pathways
through which HAND2 promotes cell survival are
unknown.
Pathways triggered by both extracellular and intracellular
signals can lead to the proteolytic cascade characteristic of
cells undergoing programmed cell death (apoptosis) (Li and
Yuan, 1999). The main effectors of apoptosis are cysteine278 (2005) 155–162
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across species (Budihardjo et al., 1999; Cikala et al., 1999;
Earnshaw et al., 1999). Signaling through the cell surface
death receptor activates initiator caspase-8, which subse-
quently stimulates the effector caspases (caspases-3, -7, etc.)
that are directly responsible for degrading cellular proteins
and causing DNA fragmentation (Li and Yuan, 1999). A
similar process is activated when mitochondria are damaged
leading to release of cytochrome c (Kluck et al., 1997; Yang
et al., 1997), which together with apoptosis protease-
activating factor-1 (Apaf-1) activate caspase-9, an initiator
caspase that can activate downstream caspases (Li et al.,
1997; Zou et al., 1999).
Targeted deletions of several molecules in the apoptotic
cascade have revealed a complex overlap of function and
tissue-specific requirement of numerous factors (Ranger et
al., 2001). During development, apoptosis can be induced
or suppressed by specific pro- or anti-apoptotic stimuli,
respectively. This complex interplay between various
factors suggests a strict control on their expression or
activity (Jacobson et al., 1997). This could be at the level
of transcription, translation, or posttranslational modifica-
tions in response to specific stimuli. While many
mediators of apoptosis undergo proteolytic cleavage in
response to stimuli (Li and Yuan, 1999), the transcriptional
control of the expression of these factors is poorly
understood.
By investigating differentially expressed genes, we had
previously found that the hypoxia inducible pro-apoptotic
Bcl-2 family member Bnip3 (formerly Nip3), which
functions through the mitochondrial damage pathway
(Bruick, 2000; Chen et al., 1997; Guo et al., 2001; Regula
et al., 2002), was upregulated in the HAND2-null embryo
prior to signs of heart failure (Villanueva et al., 2002). Bnip3
localizes to the mitochondria (Yasuda et al., 1998) and is
implicated in hypoxia-induced apoptosis in cardiomyocytes
(Guo et al., 2001; Kubasiak et al., 2002; Regula et al.,
2002). Here, we investigated the apoptotic cascades affected
by HAND2 during mouse embryonic development. Apaf-1,
a downstream mediator of mitochondrial-induced apoptosis
(Li et al., 1997; Zou et al., 1997), was required for the
apoptosis observed in HAND2-null pharyngeal and aortic
arch mesenchyme, as in vivo loss of Apaf-1 partially
rescued mesenchymal apoptosis in HAND2-null embryos
and delayed embryonic lethality. Despite prolonged survival
until E11.0, ventricular hypoplasia and cell death was
unchanged in HAND2/Apaf-1/ embryos. These results
suggest that HAND2, in addition to regulating differ-
entiation and expansion of specific cell types (Yamagishi
et al., 2000, 2001), functions by regulating survival of
pharyngeal arch mesenchyme through an Apaf-1-mediated
pathway. This study also revealed that the early lethality
observed in HAND2-null embryos is partly due to loss of
pharyngeal arch and aortic arch artery integrity, and that
hypoplasia of the right ventricle is independent of the arch
artery defects.Materials and methods
Generation of HAND2/Apaf-1/ embryos
Mice heterozygous for the HAND2 mutation (Srivastava
et al., 1997) or Apaf-1 mutation (Honarpour et al., 2000)
were generated and genotyped as described previously on a
C57BL/6 or SV129 background, respectively. Apaf-1
mutant animals in a C57BL/6 background were generated
by back-crossing with wild-type C57BL/6 mice for seven
generations. Mice heterozygous for the HAND2 mutant
allele or the Apaf-1 mutant allele were intercrossed and their
progeny was genotyped to identify double heterozygous
(HAND2+/Apaf-1+/) pups. Pregnancies resulting from
intercrosses of HAND2+/Apaf-1+/ animals were termi-
nated at varying points during gestation by cesarean section
and embryos were fixed overnight in 4% paraformaldehyde/
PBS. Yolk sac DNA was used to genotype the Apaf-1
mutant allele by PCR and the HAND2 mutant allele by
Southern to identify embryos that were homozygous for
both mutations.
Histology
Wild type, HAND2/, HAND2/Apaf-1+/ and
HAND2/Apaf-1/ embryos were embedded in paraffin
after fixation. Transverse sections were made through the
embedded tissue at 5-Am intervals. Paraffin was cleared
with xylene and select sections were counter-stained with
hematoxylin and eosin.
Apoptosis and proliferation studies
To visualize apoptotic nuclei in pharyngeal arches, limb
buds, and hearts in situ, transverse sections of wild type,
HAND2/, HAND2/Apaf-1+/, and HAND2/Apaf-1/
embryos were subjected to terminal transferase-mediated
dUTP-biotin nick end labeling (TUNEL) using the ApopTag
kit (Intergen Company). Sections were counter-stained with
DAPI. Immunohistochemistry using antibodies to pCNA and
phosphohistone 3 was performed on sections for assaying
proliferative cells using standard methods.Results
Loss of Apaf-1 leads to partial rescue of the HAND2-null
phenotype
TUNEL analysis of HAND2/ hearts and pharyngeal
arches previously revealed increased apoptosis compared to
wild type (Thomas et al., 1998; Yamagishi et al., 2001).
Furthermore, EM studies on hearts of HAND2 mutants
showed the presence of disrupted mitochondria (unpub-
lished observations). To genetically test the hypothesis that
mitochondrial damage and subsequent caspase activation
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attempted to block mitochondrial-induced apoptotic signals
by generating HAND2-null mice in the Apaf-1-null back-
ground. Apaf-1 is a ubiquitously expressed cytosolic protein
that interacts with cytochrome c and dATP, and is required
for the activation of caspase-9 and subsequent propagation
of the apoptotic signal (Li et al., 1997; Liu et al., 1996; Zou
et al., 1997). Targeted deletion of Apaf-1 in mice results in
late embryonic or perinatal lethality due to loss of cell death
in the nervous system (Cecconi et al., 1998; Yoshida et al.,
1998).
Mice heterozygous for the HAND2 or Apaf-1 mutant
allele were intercrossed to generate trans-heterozygous
mice, all of which appeared normal. HAND2+/Apaf-1+/
mice were intercrossed and the resulting offsprings were
analyzed at E10.5. This stage was chosen for initial
analysis because HAND2/ embryos at this stage are
severely malformed with pericardial effusion, a sign of
cardiac failure, and many are already dead with their
growth having been arrested at E9.5. As expected, all
embryos lacking HAND2 alone were growth retarded, hadFig. 1. Decrease in Apaf-1 gene dosage leads to partial rescue of the HAND2/
HAND2/Apaf-1+/ (C, G, and K), and HAND2/Apaf-1/ (D, H, and L) are
and HAND2/Apaf-1/ embryos had better developed limb buds (lb) in C a
compared to the HAND2/ embryo (B and F). However, HAND2/Apaf-1+/ a
and L) similar to the HAND2/ embryo (J). HAND2/Apaf-1+/ and HAND2
effusion (pe) as seen in HAND2/ embryos (F). Images A–D were captured at the
images of A–D, respectively, and focus on the heart and pharyngeal arches. h, heextremely small pharyngeal arches, and showed severe
cardiac failure as evidenced by pericardial effusion (Fig. 1).
In contrast, HAND2/Apaf-1/ embryos had well-pre-
served pharyngeal arches and limb buds, and showed no
pericardial effusion (Fig. 1), suggesting significant rescue
of HAND2/ embryos. HAND2/Apaf-1+/ embryos
showed an intermediate phenotype with respect to preser-
vation of the pharyngeal arches and pericardial effusion
(Fig. 1).
Unlike the rescue of the pharyngeal arches, the cardiac
phenotype in HAND2/, HAND2/Apaf-1+/, and
HAND2/Apaf-1/ embryos was identical at E10.5.
Hypoplasia of the right ventricle in HAND2/ embryos
manifests prior to the pharyngeal arch phenotype and is
apparent as early as E8.5. Therefore, in an effort to deter-
mine whether loss of Apaf-1 might have rescued the early
cardiac phenotype, HAND2/ and HAND2/Apaf-1/
embryos were harvested at E9.0–9.5. Even at this early
stage, we observed a hypoplastic right ventricle and thin left
ventricle in HAND2/Apaf-1/ embryos (Fig. 2), suggest-
ing that reduction of Apaf-1 dosage did not rescue the myo-phenotype. Embryos of wild type (A, E, and I), HAND2/ (B, F, and J),
shown in frontal (A–H) and right lateral (I–L) views. HAND2/Apaf-1+/
nd D, respectively, and pharyngeal arches (pa) in G and H, respectively,
nd HAND2/Apaf-1/ embryos showed absence of the right ventricle (K
/Apaf-1/ embryos (G and H, respectively) did not exhibit pericardial
same magnification, as were images I–L. Frontal views in E–H are close-up
ad; lv, left ventricle; rv, right ventricle; ot, outflow tract.
Fig. 2. Cardiac defect in HAND2/Apaf-1/ embryos at E 9.0–9.5. Right lateral views of E9.5 wild-type (A), HAND2/ (B), and HAND2/Apaf-1/ (C)
embryos focusing on cardiac region. Double mutant embryos had a small right ventricle segment (arrow in C), as did HAND2/ embryos (arrow in B). Images
are shown at equal magnification. Transverse sections through wild type (D and G), HAND2/ (E and H), and HAND2/Apaf-1/ (F and I) are shown after
TUNEL assay (G–I) and counter stained with DAPI (D–F). Bright green cells represent cells undergoing apoptosis (TUNEL positive). Arrows in E, F, H, and I
indicate the reduced right ventricle. a, atrium; lv, left ventricle; rv, right ventricle; ot, outflow tract; pa, pharyngeal arches.
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sistent ventricular defects, we did not detect any differences
in apoptosis upon comparing hearts of HAND2/Apaf-1/
to HAND2/ embryos from E9.0 to E9.5 (Fig. 2D–I).
HAND2 mutants do not have any detectable proliferative
defects and we also did not detect any changes in cardiac
proliferation nor gene expression (e.g., Nkx2.5, Mlc2v,
Tbx5, Hand1) in the presence or absence of Apaf-1 alleles
(data not shown), suggesting that the molecular events in the
ventricles of HAND2 mutants were independent of Apaf-1
dosage. Ultimately, the failure of myocardial development
led to growth arrest beyond E11.0.
Because the initial analyses were done in a C57BL6/
SV129 mixed background, we asked whether the partial
rescue might be due to genetic modifiers in the SV129
background. To answer this question, Apaf-1 mice were
back-crossed into the C57BL6 background to achieve
greater than 90% pure animals that were then used toTable 1
Genotype of embryos from HAND2+/Apaf-1+/ intercrosses
Genotype HAND2 +/+ +/+ +/+ +/
Apaf-1 +/+ +/ / +/+
E9.5 Observed 6 9 5 10
Expected 4 8 4 8
E10.5–11.0 Observed 16 25 13 24
Expected 11 21 11 21
Expected ratio 1/16 1/8 1/16 1/8generate HAND2/ Apaf-1/ embryos. HAND2/
Apaf-1/ embryos in the nearly pure C57BL6 back-
ground at E10.5–11.0 showed the same results as those
seen in the C57BL6/SV129 mixed background (Table
1). These results indicated that Apaf-1 function was
required to mediate the early hypoplasia seen in the
pharyngeal arches of HAND2/ embryos.
To determine the mechanism of partial rescue, sections
through the pharyngeal arches and limb buds of HAND2/
and HAND2/Apaf-1/ were analyzed using the TUNEL
assay to determine the extent of cell death. When embryos
were compared at E10.5, the numbers of apoptotic cells
were remarkably reduced in the HAND2/Apaf-1/
embryos compared to HAND2/ embryos (Fig. 3). E9.5
HAND2/ embryos were used for comparison with E10.5–
11.0 HAND2/Apaf-1/ embryos because by E10.5 the
pharyngeal arches of HAND2/ embryos are severely
hypoplastic and the embryo is being reabsorbed. Our results+/ +/ / / / Tota
+/ / +/+ +/ /
19 8 3 4 3 67
17 8 4 8 4
48 22 2 9 8 167
42 21 11 21 11
1/4 1/8 1/16 1/8 1/16l
Fig. 3. Decreased apoptosis in pharyngeal arches and limb buds of HAND2/Apaf-1/ and HAND2/Apaf-1+/ embryos. Transverse sections through wild
type (A and E), HAND2/ (B and F), HAND2/Apaf-1+/(C and G), and HAND2/Apaf-1/ (D and H) are shown after TUNEL assay (E–H) and counter
stained with DAPI (A–D). Bright green cells represent cells undergoing apoptosis (TUNEL positive). nt, neural tube; pa, pharyngeal arch.
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Apaf-1/ embryos were still healthy and did not
demonstrate excessive apoptosis. We also examined
apoptosis in limb buds of wild type, HAND2/, and
HAND2/Apaf-1/ embryos. As in the pharyngeal arches,
we observed a decrease in the apoptosis in HAND2/
Apaf-1/limb buds in comparison to HAND2/ embryos
at E9.5 (Fig. 4) but no changes in expression of genes
such as sonic hedgehog, thought to be downstream of
HAND2 in the limb bud.
Our previous studies demonstrated that HAND2/
embryos have vascular defects with the most prominent
being atresia of the pharyngeal arch arteries (Srivastava et
al., 1997). The early closure of these vessels that connect the
cardiac outflow tract (conotruncus) to the aorta resulted in
dilation of the aortic sac (Srivastava et al., 1997; Yamagishi
et al., 2000). Because HAND2 was expressed in the right
ventricle and pharyngeal arches, it has remained unclear
whether the early lethality was due to the intrinsicFig. 4. Decreased apoptosis in limb buds of HAND2/Apaf-1/ embryos. Sect
Apaf-1/ (C and F) are shown after TUNEL assay (D–F) and counter stained
(TUNEL positive). lb, limb bud.myocardial defect or was a result of the pharyngeal arch
artery defect. Because HAND2/Apaf-1/ embryos sur-
vived longer than HAND2/ embryos in spite of similar
right ventricular defects, we carefully examined sections
through the pharyngeal arches of HAND2/Apaf-1/
embryos to determine the patency of the pharyngeal arch
arteries. Mice lacking both genes not only survived longer,
but also had well-preserved pharyngeal arch arteries (Fig. 5)
that were unobstructed. In HAND2 single mutants, the aortic
sac becomes aneurysmally dilated by E10.0, likely secon-
dary to closure of the pharyngeal arch arteries that arise
from the aortic sac. Consistent with patency of the
pharyngeal arch arteries in HAND2/Apaf-1/, the aortic
sac in double mutants was not aneurysmally dilated (Figs.
1K and L compared to Fig. 1J), even at E11. This result
suggests that the right ventricular defect in HAND2 mutants
is not a consequence of obstructed blood flow since right
ventricular hypoplasia was still observed in HAND2/
Apaf-1/ embryos (Fig. 5). Rather, atresia of the archions through wild type (A and D), HAND2/ (B and E), and HAND2/
with DAPI (A–C). Bright green cells represent cells undergoing apoptosis
Fig. 5. Histological analysis of HAND2/Apaf-1/ embryos. Transverse (A–C) and sagittal (D–F) sections through wild-type (A and D), HAND2/ (B and
E), and HAND2/Apaf-1/ embryos (C and F) are shown. HAND2/animals showed absence of the right ventricle and a poorly developed left ventricle
irrespective of Apaf-1 dosage (B and C). HAND2/Apaf-1/ embryos, however, had better developed pharyngeal arches (arrowheads in F) with patent arch
arteries (asterisk in F) compared to HAND2/ embryos (E) at E10.0, which had loss of cells in the arch mesenchyme and atresia of the arch arteries
(arrowheads in E) and dilated aortic sac (as). a, atrium; ot, outflow tract; lv, left ventricle; rv, right ventricle.
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embryos.Discussion
The partial rescue of the HAND2 mutant phenotype in
the Apaf1-null background supports the hypothesis that the
apoptosis observed in HAND2-null embryos occurs in part
through nonreceptor-mediated activation of a caspase path-
way. Our results also suggest that the atresia of pharyngeal
arch arteries might be the primary cause of cardiac failure in
HAND2 mutants and that the right ventricular defect is not
secondary to obstruction of blood flow from the cardiac
outflow tract.
Apoptosis observed in the right ventricle and pharyngeal
arches of HAND2/ embryos may occur via different
pathways
HAND2/ embryos exhibit hypoplasia of the right
ventricle at E8.5 and pharyngeal arches at E9.5 due to robustapoptosis (Thomas et al., 1998; Yamagishi et al., 2001).
Electron microscopy and comparative gene expression
analysis suggested a mitochondrial damage-induced path-
way caused this apoptosis. Consistent with this, loss of
Apaf-1 blocked apoptosis in the pharyngeal arches and limb
bud of HAND2/ embryos. Apaf-1 is a cytosolic protein,
which in the presence of ATP and cytochrome c can activate
pro-caspase-9, an initiator caspase leading to activation of
other caspases (Li et al., 1997; Zou et al., 1997). This causes
proteolysis and DNA fragmentation in the cell, which is
ultimately engulfed by macrophages and cleared. Although
most intracellular apoptotic pathways require Apaf-1, other
signals transduced by death receptor pathways can also
result in apoptosis. Since loss of Apaf-1 only affected
pharyngeal arch and limb bud apoptosis, there are likely
Apaf-1-independent mechanisms that regulate cell death in
the right ventricle of HAND2 mutants. These could be
through death receptors or may represent a default pathway
secondary to a differentiation defect in the absence of
HAND2, although we cannot distinguish between these
alternatives. It is also possible that cells of the cardiac
lineage are more sensitive to the necrosis-like cell death
A.R. Aiyer et al. / Developmental Biology 278 (2005) 155–162 161seen in Apaf-1-deficient embryonic fibroblasts (Miyazaki et
al., 2001) and in limb buds of Apaf-1-deficient mice
(Chautan et al., 1999).
Loss of pharyngeal arch arteries in HAND2/ embryos is
partially responsible for early lethality
In the pharyngeal arches of HAND2 mutants, apoptosis
of the arch mesenchyme coupled with loss of VSMC
specification causes hypoplasia of the pharyngeal arch
artery (Thomas et al., 1998; Yamagishi et al., 2000).
Although these studies were performed in HAND2/
embryos at E9.5 prior to the presence of cardiac distress,
there remained the possibility that the pharyngeal arch
defect is in some way related to hemodynamic changes
caused by the hypoplastic right ventricle and thin walled left
ventricle. Therefore, it has been difficult to determine if the
early lethality of the HAND2/ embryo was a result of
ventricular hypoplasia or if the pharyngeal arch defects
might play a causative role in the E9.5 growth arrest of
HAND2/ embryos.
We have analyzed pharyngeal arches of HAND2/
embryos with decreased dosage or absence of Apaf-1 at
E10.5–11.0. At this stage, HAND2/ embryos with normal
Apaf-1 dosage are dead, with a complete absence of cells in
the pharyngeal arches and severe pericardial effusion caused
by cardiac failure. Loss of Apaf-1 function, however,
maintained the integrity of the pharyngeal arch and the
arch artery in HAND2/ embryos. These HAND2/Apaf-
1/ embryos did not exhibit pericardial effusion at E10.5,
suggesting that maintenance of the arch arteries reduced
cardiac stress leading to longer survival of the animals,
consistent with a primary role for the pharyngeal arch
arteries in the cardiac failure observed in HAND2/
embryos at E9.5. The failure of myocardial development
in HAND2/Apaf-1/ embryos ultimately leads to growth
arrest beyond E11.0 when the embryo requires a more
vigorous circulation.
In this study, we investigated the apoptotic pathway
activated in the absence of HAND2. We have shown that
loss of Apaf-1 leads to a partial rescue of the HAND2/
phenotype by blocking apoptosis in the pharyngeal arch
mesenchyme, indicating that arch artery defects in
HAND2/ embryos contribute to the early lethality. Our
results also show that the right ventricular hypoplasia in
HAND2/ embryos is independent of the arch defect and
possibly results via an Apaf-1-independent mechanism. The
identification of distinct enhancers controlling cardiac and
pharyngeal arch expression of HAND2 (Charite et al., 2001;
McFadden et al., 2000) provides an important tool for the
study of HAND2 function during the development of these
two tissues. Deletion of an ET-1- and Dlx6-dependent
pharyngeal arch HAND2 enhancer causes craniofacial
defects in mice harboring the homozygous deletion (Yana-
gisawa et al., 2003); however, these mice continue to
express HAND2 in the ventral regions of the pharyngealarches. Targeted deletion of HAND2 in specific tissues will
more definitively reveal its independent roles in embryonic
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